Nonrandom chromosomal aberrations and cytogenetic heterogeneity in gallbladder carcinomas
Corresponding Author
Ludmila Gorunova
Department of Clinical Genetics, University Hospital, Lund, Sweden
Department of Clinical Genetics, University Hospital, SE-221 85 Lund, Sweden.Search for more papers by this authorLuis Antonio Parada
Department of Clinical Genetics, University Hospital, Lund, Sweden
Search for more papers by this authorJanusz Limon
Department of Biology and Genetics, Medical University, Gdansk, Poland
Search for more papers by this authorYuesheng Jin
Department of Clinical Genetics, University Hospital, Lund, Sweden
Search for more papers by this authorMagnus Hallén
Department of Surgery, University Hospital, Lund, Sweden
Search for more papers by this authorInga Hägerstrand
Department of Pathology, University Hospital, Lund, Sweden
Search for more papers by this authorMariola Iliszko
Department of Biology and Genetics, Medical University, Gdansk, Poland
Search for more papers by this authorZdzislaw Wajda
Department of Surgery, Medical University, Gdansk, Poland
Search for more papers by this authorBertil Johansson
Department of Clinical Genetics, University Hospital, Lund, Sweden
Search for more papers by this authorCorresponding Author
Ludmila Gorunova
Department of Clinical Genetics, University Hospital, Lund, Sweden
Department of Clinical Genetics, University Hospital, SE-221 85 Lund, Sweden.Search for more papers by this authorLuis Antonio Parada
Department of Clinical Genetics, University Hospital, Lund, Sweden
Search for more papers by this authorJanusz Limon
Department of Biology and Genetics, Medical University, Gdansk, Poland
Search for more papers by this authorYuesheng Jin
Department of Clinical Genetics, University Hospital, Lund, Sweden
Search for more papers by this authorMagnus Hallén
Department of Surgery, University Hospital, Lund, Sweden
Search for more papers by this authorInga Hägerstrand
Department of Pathology, University Hospital, Lund, Sweden
Search for more papers by this authorMariola Iliszko
Department of Biology and Genetics, Medical University, Gdansk, Poland
Search for more papers by this authorZdzislaw Wajda
Department of Surgery, Medical University, Gdansk, Poland
Search for more papers by this authorBertil Johansson
Department of Clinical Genetics, University Hospital, Lund, Sweden
Search for more papers by this authorAbstract
Chromosome banding analysis of 11 short-term cultured gallbladder carcinomas revealed acquired clonal aberrations in seven tumors (five primary and two metastases). Three of these had one clone, whereas the remaining four were cytogenetically heterogeneous, displaying two to seven aberrant clones. Of a total of 21 abnormal clones, 18 had highly complex karyotypes and three exhibited simple numerical deviations. Double minutes and homogeneously staining regions were observed in one and two carcinomas, respectively. To characterize the karyotypic profile of gallbladder cancer more precisely, we have combined the present findings with our three previously reported cases, thereby providing the largest cytogenetic database on this tumor type to date. A total of 287 chromosomal breakpoints were identified, 251 of which were found in the present study. Chromosome 7 was rearranged most frequently, followed by chromosomes 1, 3, 11, 6, 5, and 8. The bands preferentially involved were 1p32, 1p36, 1q32, 3p21, 6p21, 7p13, 7q11, 7q32, 19p13, 19q13, and 22q13. Nine recurrent abnormalities could, for the first time, be identified in gallbladder carcinoma: del(3)(p13), i(5)(p10), del(6)(q13), del(9)(p13), del(16)(q22), del(17)(p11), i(17)(q10), del(19)(p13), and i(21)(q10). The most common partial or whole-arm gains involved 3q, 5p, 7p, 7q, 8q, 11q, 13q, and 17q, and the most frequent partial or whole-arm losses affected 3p, 4q, 5q, 9p, 10p, 10q, 11p, 14p, 14q, 15p, 17p, 19p, 21p, 21q, and Xp. These chromosomal aberrations and imbalances provide some starting points for molecular analyses of genomic regions that may harbor genes of pathogenetic importance in gallbladder carcinogenesis. Genes Chromosomes Cancer 26:312–321, 1999. © 1999 Wiley-Liss, Inc.
REFERENCES
- Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, Maeda S, Saitoh Y. 1996a. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 38: 426–429. Medline
- Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimori T, Maeda S, Saitoh Y. 1996b. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology 43: 521–526. Medline
- Bardi G, Gorunova L, Limon J, Nedoszytko B, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andrén-Sandberg Å, Rys J, Niezabitowski A, Mitelman F, Heim S. 1994. Abnormal karyotypes in three carcinomas of the gallbladder. Cancer Genet Cytogenet 76: 15–18. Medline
- Beroud C, Soussi T. 1996. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucl Acids Res 24: 121–124. Medline
- Chow NH, Huang SM, Chan SH, Mo LR, Hwang MH, Su WC. 1995. Significance of c-erB-2 expression in normal and neoplastic epithelium of biliary tract. Anticancer Res 15: 1055–1159. Medline
- Crawford JM. 1994. The liver and the biliary tract, In: RS Cotran, V Kumar, SL Robbins, editors. Robbins pathologic basis of disease, 5th ed. Philadelphia: W.B. Saunders Company. p 831–896.
- Diamantis I, Karaitopoulou E, Perentes E, Zimmermann A. 1995. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 22: 774–779. Medline
- Fazeli A, Dickinson SL, Hermiston ML, Tighe RV, Steen RG, Small CG, Stoeckli E, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M, Weinberg RA. 1997. Phenotype of mice lacking functional deleted in colorectal cancer (Dcc) gene. Nature 386: 796–804. Medline
- Fraumeni JF Jr. 1975. Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res 35: 3437–3446. Medline
- Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350–353. Medline
- Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, Schwarte-Waldhoff I, Maschek H, Schmiegel W. 1998. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res 58: 1124–1126. Medline
- Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Iwao T, Eguchi N, Sasaki T, Matsubara K, Kajiyama G. 1997. TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. Eur J Cancer 33: 1136–1140. Medline
- Hecht F, Kuban DJ, Berger C, Kaiser-McCaw Hecht B, Sandberg AA. 1983. Adenocarcinoma of the gallbladder: chromosome abnormalities in a genetic form of cancer. Cancer Genet Cytogenet 8: 185–190. Medline
- Höglund M, Gorunova L, Jonson T, Dawiskiba S, Andrén-Sandberg Å, Stenman G, Johansson B. 1998. Cytogenetic and FISH analyses of pancreatic carcinoma reveal breaks in 18q10–11 with consistent loss of 18q12-ter and frequent gain of 18p. Br J Cancer 77: 1893–1899. Medline
- 1995. An International System for Human Cytogenetic Nomenclature. F Mitelman, editor. Basel: S Karger.
-
Imai M,
Hoshi T,
Ogawa K.
1994.
K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturating gradient gel electrophoresis.
Cancer
73: 2727–2733.
Medline
10.1002/1097-0142(19940601)73:11<2727::AID-CNCR2820731113>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- Itoi T, Watanabe H, Ajioka Y, Oohashi Y, Takel K, Nishikura K, Nakamura Y, Horil A, Saito T. 1996. APC, K-ras codon 12 mutations and correlation of p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathol Int 46: 333–340. Medline
- Itoi T, Watanabe H, Yoshida M, Ajioka Y, Nishikura K, Saito T. 1997. Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas. Pathol Int 47: 525–530. Medline
- Johansson B, Mertens F, Mitelman F. 1991. Geographic heterogeneity in neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 3: 1–7. Medline
- Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F. 1993. Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer 6: 199–205. Medline
- Jonas S, Springmeier G, Tauber R, Wiedenmann B, Gessner R, Kling N, Lobeck H, Fieger C, Bechstein WO, Neuhaus P. 1997. p53 hot-spot mutational analysis in advanced Western gallbladder carcinoma. World J Surg 21: 768–772. Medline
-
Jonson T,
Gorunova L,
Dawiskiba S,
Andrén-Sandberg Å,
Stenman G,
ten Dijke P,
Johansson B,
Höglund M.
1999.
Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.
Genes Chromosomes Cancer
24: 62–71.
Medline
10.1002/(SICI)1098-2264(199901)24:1<62::AID-GCC9>3.0.CO;2-4 CAS PubMed Web of Science® Google Scholar
- Kamel D, Paakko P, Nuorva K, Vahakangas K, Soini Y. 1993. p53 and c-erB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 170: 67–72. Medline
- Lee CS. 1996. Differences in c-fos gene product expression in cancers of the gall-bladder and biliary tract. Pathol Int 46: 771–776. Medline
- Lengauer C, Kinzler KW, Vogelstein B. 1997. Genetic instability in colorectal cancers. Nature 386: 623–627. Medline
- Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instability in human cancers. Nature 396: 643–649. Medline
- Ljubimova JY, Petrovic LM, Wilson SE, Geller SA, Demetriou AA. 1997. Expression of HGF, its receptor c-met, cmyc, and albumin in cirrhotic and neoplastic human tissue. J Histochem Cytochem 45: 79–87. Medline
- Mitelman F. 1998. Catalog of chromosome aberrations in cancer '98, version 1. CD-ROM. New York: Wiley-Liss.
- Mitelman F, Johansson B, Mandahl N, Mertens F. 1997a. Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet 95: 1–8. Medline
- Mitelman F, Mertens F, Johansson B. 1997b. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417–474. Medline
-
Nessling M,
Solinas-Toldo S,
Wilgenbus KK,
Borchard F,
Lichter P.
1998.
Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2.
Genes Chromosomes Cancer
23: 307–316.
Medline
10.1002/(SICI)1098-2264(199812)23:4<307::AID-GCC5>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
-
Parada LA,
Hallén M,
Tranberg K-G,
Hägerstrand I,
Bondeson L,
Mitelman F,
Johansson B.
1998.
Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer.
Genes Chromosomes Cancer
23: 26–35.
Medline
10.1002/(SICI)1098-2264(199809)23:1<26::AID-GCC5>3.0.CO;2-8 CAS PubMed Web of Science® Google Scholar
- Roa I, Araya JC, Shiraishi T, Yatani R, Wistuba I, Villaseca M, de Aretxabala X. 1994. Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products. Rev Med Chil 122: 754–759. Medline
- Rys J, Kruczak A, Iliszko M, Babinska M, Wasilewska A, Limon J, Niezabitowski A. 1998. Sarcomatoid carcinoma (carcinosarcoma) of the gallbladder. Gen Diagn Pathol 143: 321–325. Medline
- Saetta A, Lazaris AC, Davaris PS. 1996. Detection of ras oncogene point mutataions and simultaneous proliferative fraction estimation in gallbladder cancer. Pathol Res Pract 192: 532–540. Medline
- Suzuki T, Kakita A, Okudaira M. 1993. An immunohistochemical and molecular biological study of c-erbB-2 amplification and prognostic relevance in gallbladder cancer. Pathol Res Pract 189: 283–292. Medline
- Tamura G, Maesawa C, Suzuki Y, Ogasawara S, Terashima M, Saito K, Satodate R. 1993. Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn J Cancer Res 84: 1015–1018. Medline
- Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, Terashima M, Saito K, Satodate R. 1996. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res 56: 612–615. Medline
- Tsuda T, Nakatani H, Tahara E, Sakamoto H, Terada M, Sugimura T. 1989. HST1 and INT2 gene coamplification in a squamous cell carcinoma of the gallbladder. Jpn J Clin Oncol 19: 26–29. Medline
- Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. 1994. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 107: 1147–1153. Medline
- Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF. 1995. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 55: 2511–2515. Medline
- Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. 1996. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 27: 360–365. Medline
- Yokoyama N, Hitomi J, Watanabe H, Ajioka Y, Pruyas M, Serra I, Shirai Y, Hatakeyama K. 1998. Mutations p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol Biomarkers Prev 7: 297–301. Medline
- Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K. 1995. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55: 2756–2760. Medline
- Yukawa M, Fujimori T, Hirayama D, Idei Y, Ajiki T, Kawai K, Sugiura R, Maeda S, Nagasako K. 1993. Expression of oncogene products and growth factors in early gallbladder cancer, advanced gallbladder cancer, and chronic cholecystitis. Hum Pathol 24: 37–40. Medline